XM does not provide services to residents of the United States of America.

Bunzl, Equinor ASA, L'Oreal



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EUROPE RESEARCH ROUNDUP-Bunzl, Equinor ASA, L'Oreal</title></head><body>

Oct 14 (Reuters) -Securities analysts revised their ratings and price targets on several European companies, including Bunzl, Equinor ASA and L'Oreal, on Monday.

HIGHLIGHTS

* Adidas AG ADSGn.DE: UBS raises target price to EUR 279 from EUR 275

* Bunzl BNZL.L: JP Morgan raises to overweight from neutral

* Equinor ASA EQNR.OL: Morgan Stanley raises to equal weight from underweight

* L'Oreal OREP.PA: Citigroup cuts target price to EUR 420 from EUR 440

* Mercedes-Benz Group AG MBGn.DE: Morgan Stanley cuts target price to EUR 72 from EUR 82

Following is a summary of research actions on European companies reported by Reuters on Monday. Stock entries are in alphabetical order.


* 1Spatial PLC SPA.L: Panmure Liberum raises target price to 90p from 80p

* Adidas AG ADSGn.DE: TD Cowen raises target price to EUR 267 from EUR 212

* Adidas AG ADSGn.DE: UBS raises target price to EUR 279 from EUR 275

* Air Liquide AIRP.PA: UBS raises target price to EUR 200 from EUR 195

* Airbus AIR.PA: Barclays cuts target price to EUR 161 from EUR 170

* Airbus SE AIR.PA: RBC cuts target price to EUR 160 from EUR 180

* Akzo Nobel NV AKZO.AS: UBS cuts target price to EUR 72 from EUR 78

* Argan ARGAN.PA: KBC Securities initiates coverage with "accumulate"; PT EUR 90

* Arkema SA AKE.PA: UBS cuts target price to EUR 105 from EUR 115

* AstraZeneca AZN.L: Guggenheim cuts target price to 13,000p from 13,200p

* BASF SE BASFn.DE: UBS cuts target price to EUR 48 from EUR 51

* BASF SE BASFn.DE: UBS cuts to neutral from buy

* Biotalys BTLS.BR: KBC Securities cuts PT to EUR 5.20 from EUR 6; rating "buy"

* BMW BMWG.DE: Morgan Stanley cuts target price to EUR 85 from EUR 102

* Bossard Holding AG BOS.S: Stifel cuts target price to CHF 210 from CHF 225

* Bper Banca EMII.MI: Deutsche Bank raises target price to EUR 6.10 from EUR 5.10

* Breedon Group BREE.L: UBS raises target price to 485p from 460p

* Bunzl BNZL.L: JP Morgan raises target price to 3,980p from 3,660p

* Bunzl BNZL.L: JP Morgan raises to overweight from neutral

* Campari CPRI.MI: Citigroup cuts target price to EUR 10 from EUR 10.10

* Compass Group CPG.L: Citigroup cuts to neutral from buy

* Covestro AG 1COV.DE: UBS raises target price to EUR 62 from EUR 52

* Datwyler Holding AG DAE.S: UBS cuts target price to CHF 174 from CHF 188

* Davide Campari-Milano NV CPRI.MI: UBS cuts target price to EUR 10.50 from EUR 11.50

* Deutsche Boerse AG DB1Gn.DE: JP Morgan cuts target price to EUR 196 from EUR 198

* Deutsche Telekom AG DTEGn.DE: Morgan Stanley raises PT to EUR 33 from EUR 31

* Dometic Group AB (Publ) DOMETIC.ST: Jefferies cuts target price to SEK 71 from SEK 80

* Dometic Group AB Publ DOMETIC.ST: Nordea raises to hold from sell

* Elior Group SA ELIOR.PA: Citigroup raises target price to EUR 5.50 from EUR 4.90

* Endeavour Mining Plc EDV.L: Berenberg cuts target price to 2,100p from 2,200p

* Equinor ASA EQNR.OL: Morgan Stanley raises to equal weight from underweight

* Evonik Industries AG EVKn.DE: UBS raises target price to EUR 22 from EUR 19

* Fidelity China Special Situations Plc FCSS.L: Jefferies initiates coverage with hold rating

* Fuller Smith & Turner Plc FSTA.L: Stifel raises target price to 750p from 660p

* Galp Energia GALP.LS: HSBC initiates coverage with buy rating and PT EUR 20

* GEA Group AG G1AG.DE: Morgan Stanley raises target price to EUR 52 from EUR 51

* Givaudan SA GIVN.S: UBS raises target price to CHF 4,520 from CHF 4,500

* GSK GSK.L: Guggenheim cuts target price to 1,785p from 1,898p

* Hays HAYS.L: RBC cuts target price to 110p from 125p

* Heidelberg Materials HEIG.DE: UBS raises target price to EUR 106 from EUR 105

* Humana AB HUMAN.ST: Kepler Cheuvreux raises target price to SEK 43 from SEK 36

* Humana AB HUMAN.ST: Kepler Cheuvreux raises to buy from hold

* Ipsos SA ISOS.PA: Berenberg cuts target price to EUR 85 from EUR 87

* Johnson Matthey JMAT.L: UBS cuts target price to 1,625p from 1,950p

* Jost Werke SE JST.DE: Berenberg cuts target price to EUR 52 from EUR 55

* Kemira Oyj KEMIRA.HE: HSBC cuts target price to EUR 21 from EUR 22

* Lanxess AG LXSG.DE: UBS raises target price to EUR 30 from EUR 24

* Liontrust Asset Management Plc LIO.L: Barclays cuts target price to 660p from 700p

* Logista LOG.MC: Kepler Cheuvreux cuts to hold from buy

* Logista LOG.MC: Kepler Cheuvreux raises target price to EUR 28.70 from EUR 27

* L'Oreal OREP.PA: Citigroup cuts target price to EUR 420 from EUR 440

* Mercedes-Benz Group AG MBGn.DE: Morgan Stanley cuts target price to EUR 72 from EUR 82

* Merck KGaA MRCG.DE: Deutsche Bank cuts target price to EUR 180 from EUR 188

* Munters Group AB MTRS.ST: Carnegie cuts to sell from hold

* Munters Group AB MTRS.ST: Carnegie lowers target price to SEK 200 from SEK 225

* Novo Nordisk NOVOb.CO: Guggenheim cuts target price to DKK 1,012 from DKK 1,013

* OMV AG OMVV.VI: HSBC initiates coverage with buy rating and target price EUR 46

* Pluxee NV PLX.PA: Goldman Sachs cuts to sell rating

* Prudential PRU.L: UBS raises target price to 1,160p from 1,090p

* Sanofi SASY.PA: Guggenheim cuts target price to EUR 126 from EUR 127

* Scout24 SE G24n.DE: HSBC raises target price to EUR 81 from EUR 76

* Solaria SLRS.MC: Berenberg cuts target price to EUR 14 from EUR 21

* Solvay SOLB.BR: UBS raises target price to EUR 36 from EUR 32

* Stellantis NV STLAM.MI: Morgan Stanley cuts target price to EUR 14 from EUR 19

* Syensqo SA SYENS.BR: UBS cuts target price to EUR 89 from EUR 108

* Synthomer SYNTS.L: UBS cuts target price to 205p from 300p

* Victrex Plc VCTX.L: UBS cuts target price to 850p from 1,000p

* Volkswagen AG VOWG_p.DE: Morgan Stanley cuts target price to EUR 86 from EUR 97

* Wacker Chemie AG WCHG.DE: UBS cuts target price to EUR 110 from EUR 137

* Wizz Air WIZZ.L: Citigroup cuts target price to 1,000p from 1,300p

* Yara YAR.OL: UBS raises target price to NOK 350 from NOK 325



(Compiled by Bengaluru Newsroom)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.